You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Immunotherapy biomarkers
Short report
Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

 

Online download statistics by month:

Online download statistics by month: March 2020 to May 2023

AbstractFullPdf
Mar 202015515558
Apr 2020686829
May 20201711718
Jun 202012712723
Jul 2020565618
Aug 202034349
Sep 2020797948
Oct 2020848437
Nov 2020242413
Dec 2020202013
Jan 202133339
Feb 2021262610
Mar 2021232314
Apr 202131319
May 2021242414
Jun 2021272716
Jul 202122225
Aug 202119196
Sep 2021323210
Oct 2021232333
Nov 2021393927
Dec 202127276
Jan 2022303210
Feb 202237408
Mar 2022293112
Apr 2022414517
May 2022333413
Jun 202247486
Jul 202223246
Aug 202236379
Sep 2022202110
Oct 2022343618
Nov 2022232515
Dec 202216183
Jan 202312126
Feb 202338385
Mar 202318196
Apr 2023442
Total15851608561